MC
CVRS

Menta Capital’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Menta Capital’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$239K Buy
+80,311
New +$201K 0.1% 351

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Menta Capital's CVRS Position: Q2 2019 in Review

Menta Capital opened a new position in CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q2 2019: 80,311 shares worth $239K. The stake represents 0.1% of the portfolio and ranks #351 among its holdings.

81 funds tracked by Wall St. Rank hold CVRS as of Q2 2019.

  • Menta Capital held 80,311 shares of CORINDUS VASCULAR ROBOTICS, INC worth $239K as of Q2 2019.
  • CORINDUS VASCULAR ROBOTICS, INC was a new Menta Capital position in Q2 2019.
  • CORINDUS VASCULAR ROBOTICS, INC made up 0.1% of Menta Capital's portfolio in Q2 2019, its #351 holding.
  • 81 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.